Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jan 09, 2024 4:48pm
139 Views
Post# 35818225

RE:RE:New company video

RE:RE:New company video "new collaboration with a major glioblastoma foundation in the US" - so?

A glioblastoma diagnosis is basically a death sentence, it's just a matter of time, 12-15 months or less. About 1000 Canadians (multply by 10 for US numbers) are diagnosed yearly. There is currently no cure and treatments are minimally efective. If it was detected early by Aristotle the only sure thing would be that one would have a longer period of time to contemplate one's pending death and get one's estate in order.

I think this is a waste of company resources, more like a diversion away from the failure to sell Aristotle.

"Expansion into Europe" Have I heard this line before? Yes, multiple times, tired of Tripp informing me of population of Europe, I already know that.

How about some real news - for example Aristotle sales.

Queue the nasty pumpers. 
LithLover wrote: Some new info on glioblastoma (brain and spinal cord cancer)  at around the 2:30 mark. 

"new collaboration with a major glioblastoma foundation in the US" 

Adding it to Aristotle as so far there is no early detection test for it.  Expansion into Europe.

Lots to unpack in this short video.



<< Previous
Bullboard Posts
Next >>